ERC FP7: Sara Richter


DocProject:  HIV LTR G-4 – G-quadruplexes in the HIV-1 genome: novel targets for the development of selective antiviral drugs


Sara Richter

 

ERC Grantee: Sara Richter

Department: Molecular Medicine

Total Contribution: Euro 1.989.471,00

Project Duration in months: 72

Start Date: 01/05/2014
End Date: 01/05/2020

Personal page

 

Sara Richter is Full Professor of Microbiology and Clinical Microbiology at the Department of Molecular Medicine.

She obtained her Master degree in Pharmaceutical Chemistry and Technology (1997) and her PhDs in Pharmaceutical Sciences (2001) and in Virology (2005) at the University of Padova. She was postdoctoral fellow at the University of Medicine and Dentistry of New Jersey, USA (1999-2001) and at the University of Padova (2001-2004). Since 2006 she is Professor at the University of Padova and works as first level manager at the Microbiology and Virology Unit of the Padua Hospital.

Her research interests focus on nucleic acid secondary structures (i.e. G-quadruplex), on antiviral and anti-HIV-1 compounds, and on the development of antitumor drugs. Her research on anticancer therapy was funded by the Italian Ministry of Education and Research on a project approved as an ERC Starting grant (2007), while her research on HIV-1 was funded by two Bill & Melinda Gates Grand Challenges Explorations grants (2011, 2013) and by an ERC Consolidator grant (2014-2019). She also won the Young Investigator Award (2000) at University of Medicine and Dentistry of New Jersey, USA and the Best Poster Award (2006) by The Italian Society of Virology.

Personal site